drugset / Trial / NCT07704684
Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objective of the study will be to assess the efficacy and safety of Sacubitril/Allisartan (240mg) and Amlodipine (5mg) in patients with essential hypertension uncontrolled after 4-week treatment with Amlodipine (5mg).
Timeline
- Start
- 2023-06-28
- Primary completion
- 2025-08-26
- Completion
- 2025-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Sacubitril | Small molecule | 240 mg | — |